One mother for two species via obligate cross-species cloning in ants

The article explores the potential of an mRNA-based HIV vaccine, reporting promising results from a phase 1 clinical trial that showed the vaccine was safe and induced robust immune responses in participants. The findings suggest this approach could lead to the development of an effective HIV vaccine.